Atossa Therapeutics, Inc. (FWB:YAG) Financings

Atossa Therapeutics, Inc.

Financings

RaiseDate
Registered direct offering of common stock (or common stock equivalents) with Series A and Series B warrants
Closed: US$4.5M raised · Series A and Series B warrants exercisable six months after issuance; Series A expire… · Rodman & Renshaw LLC
Dealers: Rodman & Renshaw LLC (lead)
Use of proceeds: Clinical development of product candidates, working capital and general corporate purposes
Jun 12, 2026

Read by 6ix AI from the company's releases